Prograf

Known as: Prograft 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
051019932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
AIM To investigate the differences in the pharmacokinetics of Prograf and the prolonged release formulation Advagraf and to… (More)
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2011
2011
BACKGROUNDS Variability of blood trough concentration (C0) in immunosuppressant leads to rejection and graft loss after kidney… (More)
Is this relevant?
2010
2010
The efficacy and safety of dual-therapy regimens of twice-daily tacrolimus (BID; Prograf) and once-daily tacrolimus (QD; Advagraf… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
This multicenter, 1:1-randomized, parallel-group, noninferiority study compared the efficacy and safety of twice-daily tacrolimus… (More)
Is this relevant?
2009
2009
INTRODUCTION Advagraf is a new modified-release once-daily formulation of tacrolimus with a similar efficacy and safety profile… (More)
Is this relevant?
2005
2005
INTRODUCTION Modified release (MR) tacrolimus is an extended release formulation administered once daily. The purpose of this… (More)
Is this relevant?
2005
2005
UNLABELLED Modified release (MR) tacrolimus is an extended release formulation administered once daily (qD). The purpose of this… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Our clinical trial was designed to investigate the optimal combination of immunosuppressants for renal transplantation… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
We report the results of a phase III open-label, randomized, multicenter trial comparing tacrolimus/methotrexate to cyclosporine… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1996
1996
Prograf (FK506) was given to male mature rats in a daily subcutaneous dose of 1 or 3 mg/kg/day for 2 weeks to investigate its… (More)
Is this relevant?